Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.
- DOI
- 10.1186/s13046-024-03214-5
- Published
- 2024 Nov 4
- Container
- Journal of experimental & clinical cancer research : CR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-024-03214-5,
title = {Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.},
author = {de Freitas JT and Thakur V and LaPorte KM and Thakur VS and Flores B and Caicedo V and Ajaegbu CGE and Ingrasci G and Lipman ZM and Zhang K and Qiu H and Malek TR and Bedogni B},
year = {2024},
journal = {Journal of experimental \& clinical cancer research : CR},
doi = {10.1186/s13046-024-03214-5},
url = {https://doi.org/10.1186/s13046-024-03214-5}
}RIS
TY - JOUR TI - Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME. AU - de Freitas JT AU - Thakur V AU - LaPorte KM AU - Thakur VS AU - Flores B AU - Caicedo V AU - Ajaegbu CGE AU - Ingrasci G AU - Lipman ZM AU - Zhang K AU - Qiu H AU - Malek TR AU - Bedogni B PY - 2024 JO - Journal of experimental & clinical cancer research : CR DO - 10.1186/s13046-024-03214-5 UR - https://doi.org/10.1186/s13046-024-03214-5 ER -
APA
JT, D. F., V, T., KM, L., VS, T., B, F., V, C., CGE, A., G, I., ZM, L., K, Z., H, Q., TR, M., & B, B. (2024). Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-024-03214-5
Source records
- pubmed · retrieved 2026-09-25T06:43:35.841Z
- europe-pmc · retrieved 2026-09-25T06:43:35.840Z